Therapeutic implications of microRNAs in pulmonary arterial hypertension

BMB Reports

Volumn 47, Issue 6, 2014, Pages 311-317

  Lee, Aram ^a   McLean, Danielle ^b   Choi, Jihea ^a   Kang, Hyesoo ^a   Chang, Woochul ^c   Kim, Jongmin ^a  

^a Sookmyung Women's University   (South Korea)

^b UNIVERSITY OF VERMONT   (United States)

^c Pusan National University   (South Korea)

Author keywords

Biomarker; MicroRNA; Pulmonary arterial hypertension; Pulmonary vascular cell; Signaling pathway

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; MICRORNA;

ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PULMONARY HYPERTENSION;

BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; HUMANS; HYPERTENSION, PULMONARY; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE;

EID: 84903603318     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.6.085     Document Type: Short Survey

References (47)

1. Sessa, R. and Hata, A. (2013) Role of microRNAs in lung development and pulmonary diseases. Pulm. Circ. 3, 315-328.
2. Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J. F., Chabot, F., Dromer, C., Pison, C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., Cottin, V., Degano, B., Jais, X., Montani, D., Souza, R. and Simonneau, G. (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122, 156-163.
3. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Friedman, R. C., Farh, K. K., Burge, C. B. and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105.
5. Hu, Z. H. (2009) Insight into microRNA regulation by analyzing the characteristics of their targets in humans. Bmc Genomics 10, 594-610.
6. Courboulin, A., Paulin, R., Giguere, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Cote, J., Simard, M. J. and Bonnet, S. (2011) Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 208, 535-548.
7. Kim, J., Kang, Y. J., Kojima, Y., Lighthouse, J. K., Hu, X. Y., Aldred, M. A., McLean, D. L., Park, H., Comhair, S. A., Greif, D. M., Erzurum, S. C. and Chun, H. J. (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat. Med. 19, 74-82.
8. Altuvia, Y., Landgraf, P., Lithwick, G., Elefant, N., Pfeffer, S., Aravin, A., Brownstein, M. J., Tuschl, T. and Margalit, H. (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33, 2697-2706.
9. Lee, Y., Kim, M., Han, J. J., Yeom, K. H., Lee, S., Baek, S. H. and Kim, V. N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060.
10. Borchert, G. M., Lanier, W. and Davidson, B. L. (2006) RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13, 1097-1101.
11. Kim, V. N. (2005) Small RNAs: Classification, biogenesis, and function. Mol. Cells 19, 1-15.
12. Kim, Y. and Kim, V. N. (2012) MicroRNA Factory: RISC assembly from precursor MicroRNAs. Mol. Cell 46, 384-386.
13. Kiss, T. (2002) Small nucleolar RNAs: An abundant group of noncoding RNAs with diverse cellular functions. Cell 109, 145-148.
14. Caruso, P., MacLean, M. R., Khanin, R., McClure, J., Soon, E., Southgate, M., MacDonald, R. A., Greig, J. A., Robertson, K. E., Masson, R., Denby, L., Dempsie, Y., Long, L., Morrell, N. W. and Baker, A. H. (2010) Dynamic changes in lung MicroRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscl. Throm. Vas. 30, 716-U182.
15. Chandra, S. M., Razavi, H., Kim, J., Agrawal, R., Kundu, R. K., Perez, V. D., Zamanian, R. T., Quertermous, T. and Chun, H. J. (2011) Disruption of the Apelin-APJ system worsens hypoxia-induced pulmonary hypertension. Arterioscl. Throm. Vas. 31, 814-U212.
16. Kim, J. (2014) Apelin-APJ Signaling: a potential therapeutic target for pulmonary arterial hypertension. Mol. Cells. 37, 196-201.
17. Hogan, B. L. (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594.
18. Long, L., Crosby, A., Yang, X., Southwood, M., Upton, P. D., Kim, D. K. and Morrell, N. W. (2009) Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 119, 566-576.
19. Machado, R. D., Aldred, M. A., James, V., Harrison, R. E., Patel, B., Schwalbe, E. C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., Eickelberg, O., Olschewski, H., Elliott, C. G., Glissmeyer, E., Carlquist, J., Kim, M., Torbicki, A., Fijalkowska, A., Szewczyk, G., Parma, J., Abramowicz, M. J., Galie, N., Morisaki, H., Kyotani, S., Nakanishi, N., Morisaki, T., Humbert, M., Simonneau, G., Sitbon, O., Soubrier, F., Coulet, F., Morrell, N. W. and Trembath, R. C. (2006) Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum. Mutat. 27, 121-132.
20. Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R. and Huber, L. C. (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 104, 1184-1191.
21. Pullamsetti, S. S., Doebele, C., Fischer, A., Savai, R., Kojonazarov, B., Dahal, B. K., Ghofrani, H. A., Weissmann, N., Grimminger, F., Bonauer, A., Seeger, W., Zeiher, A. M., Dimmeler, S. and Schermuly, R. T. (2012) Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am. J. Respir. Crit. Care Med. 185, 409-419.
22. Brock, M., Samillan, V. J., Trenkmann, M., Schwarzwald, C., Ulrich, S., Gay, R. E., Gassmann, M., Ostergaard, L., Gay, S., Speich, R. and Huber, L. C. (2012) AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur. Heart J. doi:10.1093/eurheartj/ehs060
23. Shintani, M., Yagi, H., Nakayama, T., Saji, T. and Matsuoka, R. (2009) A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J. Med. Genet. 46, 331-337.
24. Drake, K. M., Zygmunt, D., Mavrakis, L., Harbor, P., Wang, L., Comhair, S. A., Erzurum, S. C. and Aldred, M. A. (2011) Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Am. J. Respir. Crit. Care Med. 184, 1400-1408.
25. Zaidi, S. H., You, X. M., Ciura, S., Husain, M. and Rabinovitch, M. (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105, 516-521.
26. Takahashi, H., Goto, N., Kojima, Y., Tsuda, Y., Morio, Y., Muramatsu, M. and Fukuchi, Y. (2006) Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L450-458.
27. Mizuno, S., Bogaard, H. J., Kraskauskas, D., Alhussaini, A., Gomez-Arroyo, J., Voelkel, N. F. and Ishizaki, T. (2011) p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L753-761.
28. Caruso, P., Dempsie, Y., Stevens, H. C., McDonald, R. A., Long, L., Lu, R., White, K., Mair, K. M., McClure, J. D., Southwood, M., Upton, P., Xin, M., van Rooij, E., Olson, E. N., Morrell, N. W., MacLean, M. R. and Baker, A. H. (2012) A role for miR-145 in pulmonary arterial hypertension:evidence from mouse models and patient samples. Circl. Res. 111, 290-300.
29. Li, S. S., Ran, Y. J., Zhang, D. D., Li, S. Z. and Zhu, D. (2014) MicroRNA-190 Regulates Hypoxic Pulmonary Vasoconstriction by Targeting a Voltage-Gated K Channel in Arterial Smooth Muscle Cells. J. Cell. Biochem. 115, 1196-1205.
30. Gou, D., Ramchandran, R., Peng, X., Yao, L., Kang, K., Sarkar, J., Wang, Z., Zhou, G. and Raj, J. U. (2012) miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L682-691.
31. Li, S., Ran, Y., Zhang, D., Chen, J., Li, S. and Zhu, D. (2013) MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. Biochem. J. 452, 281-291.
32. Sarkar, J., Gou, D., Turaka, P., Viktorova, E., Ramchandran, R. and Raj, J. U. (2010) MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L861-871.
33. Yang, S. Z., Banerjee, S., de Freitas, A., Cui, H. C., Xie, N., Abraham, E. and Liu, G. (2012) miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am. J. Physiol-Lung C. 302, L521-L529.
34. Parikh, V. N., Jin, R. C., Rabello, S., Gulbahce, N., White, K., Hale, A., Cottrill, K. A., Shaik, R. S., Waxman, A. B., Zhang, Y. Y., Maron, B. A., Hartner, J. C., Fujiwara, Y., Orkin, S. H., Haley, K. J., Barabasi, A. L., Loscalzo, J. and Chan, S. Y. (2012) MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension results of a network bioinformatics approach. Circulation 125, 1520-U1216.
35. Guo, L., Qiu, Z. P., Wei, L. P., Yu, X. F., Gao, X., Jiang, S. L., Tian, H., Jiang, C. and Zhu, D. L. (2012) The MicroRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-Type calcium channel-alpha 1C. Hypertension 59, 1006-1013.
36. Chen, X. Y., Yan, Q., Li, S. D., Zhou, L., Yang, H. J., Yang, Y. X., Liu, X. L. and Wan, X. P. (2012) Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ER alpha-positive endometrioid adenocarcinoma. Cancer Lett. 314, 41-53.
37. Kondo, N., Toyama, T., Sugiura, H., Fujii, Y. and Yamashita, H. (2008) miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 68, 5004-5008.
38. Jalali, S., Ramanathan, G. K., Parthasarathy, P. T., Aljubran, S., Galam, L., Yunus, A., Garcia, S., Cox, R. R., Lockey, R. F. and Kolliputi, N. (2012) Mir-206 Regulates pulmonary artery smooth muscle cell proliferation and differentiation. Plos One 7, e46808.
39. Li, X. D., Zhang, X. X., Leathers, R., Makino, A., Huang, C. Q., Parsa, P., Macias, J., Yuan, J. X. J., Jamieson, S. W. and Thistlethwaite, P. A. (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat. Med. 15, 1289-U1289.
40. Kang, K., Peng, X., Zhang, X. Y., Wang, Y. N., Zhang, L. S., Gao, L., Weng, T. T., Zhang, H. H., Ramchandran, R., Raj, J. U., Gou, D. M. and Liu, L. (2013) MicroRNA-124 suppresses the transactivation of nuclear factor of activated t cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J. Biol. Chem. 288, 25414-25427.
41. Wang, D., Zhang, H., Li, M., Frid, M. G., Flockton, A. R., McKeon, B. A., Yeager, M. E., Fini, M. A., Morrell, N. W., Pullamsetti, S. S., Velegala, S., Seeger, W., McKinsey, T. A., Sucharov, C. C. and Stenmark, K. R. (2014) MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ. Res. 114, 67-78.
42. Creemers, E. E., Tijsen, A. J. and Pinto, Y. M. (2012) Circulating microRNAs: novel biomarkers and ex tracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495.
43. Hergenreider, E., Heydt, S., Treguer, K., Boettger, T., Horrevoets, A. J., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., Braun, T., Urbich, C., Boon, R. A. and Dimmeler, S. (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14, 249-256.
44. Turchinovich, A., Weiz, L., Langheinz, A. and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233.
45. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. and Remaley, A. T. (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433.
46. Rhodes, C. J., Wharton, J., Boon, R. A., Roexe, T., Tsang, H., Wojciak-Stothard, B., Chakrabarti, A., Howard, L. S., Gibbs, J. S., Lawrie, A., Condliffe, R., Elliot, C. A., Kiely, D. G., Huson, L., Ghofrani, H. A., Tiede, H., Schermuly, R., Zeiher, A. M., Dimmeler, S. and Wilkins, M. R. (2013) Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 187, 294-302.
47. Wei, C., Henderson, H., Spradley, C., Li, L., Kim, I. K., Kumar, S., Hong, N., Arroliga, A. C. and Gupta, S. (2013) Circulating miRNAs as potential marker for pulmonary hypertension. Plos One 8, e64396.